1
|
Matichak DP, Levy AS, Vanderveer-Harris N, Chang H, Vallejo F, Schachner B, Shah AH, Komotar RJ, Chakravarthy V, Ivan ME. Trends in Leadership Among Neurosurgical Oncology Fellowships. World Neurosurg 2023:S1878-8750(23)00396-0. [PMID: 36963564 DOI: 10.1016/j.wneu.2023.03.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Revised: 03/16/2023] [Accepted: 03/17/2023] [Indexed: 03/26/2023]
Abstract
OBJECTIVE To examine current neurosurgical oncology leadership trends and provide a guide for those interested in obtaining fellowship directorship, we investigated fellowship director (FD) demographic, educational and leadership characteristics. METHODS The American Association of Neurological Surgeons (AANS) Academic Fellowship Directory and Committee on Advanced Subspecialty Training (CAST) websites were reviewed for current U.S. program FDs for which data was collected using online resources and surveys. RESULTS 23 total FDs (20 males and 3 females) were represented whose mean age was 52.4 years (SD = 8.7). Our analysis found 65% of current neurosurgical oncology FD's to be singularly trained in neurosurgical oncology, with 8.7% possessing multiple fellowships and 34.8% possessing additional degrees. Fellowship programs producing the most FDs were University of Texas MD Anderson (4), Memorial Sloan Kettering (3) and University of Miami (2). FDs possessed an average of 148 publications, 6423 citations, and an h-index of 33.9. H-index had a high-positive correlation with age and time from residency graduation, but not duration of FD appointment. Among survey respondents, 91.7% reported membership and 75% reported leadership positions among national academic societies, while 66.7% reported holding journal-editorial positions. The mean age of FD appointment was 46.8 years with a mean time from fellowship completion to FD appointment of 10.0 years. CONCLUSIONS Through the characterization of current leaders in the field, we provide valuable information with regards to training location trends, research productivity goals, career timelines, and target journal/national academic society involvement worth consideration among young trainees when making career decisions and plans.
Collapse
Affiliation(s)
- David P Matichak
- Department of Neurological Surgery, University of Miami Miller School of Medicine, 1095 NW 14(th) Terrace, Miami, FL, 33136, USA
| | - Adam S Levy
- Department of Neurological Surgery, University of Miami Miller School of Medicine, 1095 NW 14(th) Terrace, Miami, FL, 33136, USA.
| | - Nathan Vanderveer-Harris
- Herbert Wertheim College of Medicine at Florida International University, 11200 SW 8(th) St, Miami, FL 33199, USA
| | - Henry Chang
- Department of Neurological Surgery, University of Miami Miller School of Medicine, 1095 NW 14(th) Terrace, Miami, FL, 33136, USA
| | - Frederic Vallejo
- Department of Neurological Surgery, University of Miami Miller School of Medicine, 1095 NW 14(th) Terrace, Miami, FL, 33136, USA
| | - Benjamin Schachner
- Department of Neurological Surgery, University of Miami Miller School of Medicine, 1095 NW 14(th) Terrace, Miami, FL, 33136, USA
| | - Ashish H Shah
- Department of Neurological Surgery, University of Miami Miller School of Medicine, 1095 NW 14(th) Terrace, Miami, FL, 33136, USA
| | - Ricardo J Komotar
- Department of Neurological Surgery, University of Miami Miller School of Medicine, 1095 NW 14(th) Terrace, Miami, FL, 33136, USA; Sylvester Cancer Center, University of Miami Health System, 1475 NW 12(th) Ave, Miami, Florida 33136, USA
| | - Vikram Chakravarthy
- Department of Neurological Surgery, The Ohio State University Wexner Medical Center, 410 W 10(th) St, Columbus, OH 43201, USA
| | - Michael E Ivan
- Department of Neurological Surgery, University of Miami Miller School of Medicine, 1095 NW 14(th) Terrace, Miami, FL, 33136, USA; Sylvester Cancer Center, University of Miami Health System, 1475 NW 12(th) Ave, Miami, Florida 33136, USA
| |
Collapse
|
2
|
Parrish JM, Jenkins NW, Cha EDK, Lynch CP, Geoghegan CE, Mohan S, Jadczak CN, Matichak DP, Singh K. Patient-Reported Outcomes Measurement Information System Physical Function Validation for Use in Anterior Cervical Discectomy and Fusion: A 2-Year Follow-up Study. Neurospine 2021; 18:155-162. [PMID: 33819942 PMCID: PMC8021822 DOI: 10.14245/ns.2040458.229] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2020] [Accepted: 08/31/2020] [Indexed: 11/19/2022] Open
Abstract
Objective Our study aims to evaluate the correlation of Patient-Reported Outcomes Measurement Information System physical function (PROMIS PF) with legacy patient-reported outcome measures (PROMs) among patients undergoing anterior cervical discectomy and fusion (ACDF).
Methods A prospectively maintained database was retrospectively reviewed for ACDF surgeries performed between May 2015 and September 2017. Inclusion criteria were primary elective, single- or multilevel ACDFs for degenerative spinal pathology. Patients lacking preoperative or 2-year PROMIS PF surveys were excluded. Mean scores were calculated for visual analogue scale (VAS) neck, VAS arm, Neck Disability Index (NDI), 12-Item Short Form Physical Component Score (SF-12 PCS), and PROMIS PF at preoperative and 6-week, 12-week, 6-month, 1-year, and 2-year postoperative timepoints. A t-test and Pearson correlation coefficient were utilized to evaluate score improvement and PROM relationships respectively.
Results The 50 subject cohort was 60.0% male, 50% obese (body mass index ≥ 30 kg/m2) and had an average age of 50.9 years. Significant improvements were demonstrated for VAS neck and NDI at all postoperative timepoints (p < 0.001) and for SF-12 and PROMIS PF at all timepoints except 6 weeks (p ≤ 0.025). VAS arm improvement was seen up to 1 year (p ≤ 0.016). PROMIS PF demonstrated strong correlations with NDI and SF-12 PCS at all evaluated timepoints and with VAS neck at all postoperative timepoints except 6 weeks (all p < 0.01).
Conclusion PROMIS PF was strongly correlated with pain, disability, and physical function up to 2 years for patients undergoing ACDF. Our results support the long-term validity of PROMIS PF for measurement of patient-reported physical function among ACDF cohorts.
Collapse
Affiliation(s)
- James M Parrish
- Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
| | - Nathaniel W Jenkins
- Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
| | - Elliot D K Cha
- Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
| | - Conor P Lynch
- Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
| | - Cara E Geoghegan
- Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
| | - Shruthi Mohan
- Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
| | - Caroline N Jadczak
- Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
| | | | - Kern Singh
- Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA
| |
Collapse
|
3
|
Hodgens BH, McSoley MJ, Milner JE, Naik KP, Howard KR, Schwartz E, Matichak DP, Champney TH. Potential Lack of Association Between Three Vestigial Muscles in Humans: A Willed Body Donor Study. Cureus 2020; 12:e8098. [PMID: 32542153 PMCID: PMC7292683 DOI: 10.7759/cureus.8098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
PURPOSE Anatomical agenesis within a population is not well understood, with variations including but not limited to complete absence, unilateral presence, or bilateral presence. Agenesis of human vestigial muscles including the palmaris longus (PL), fibularis tertius (FT), and psoas minor (PM) has been studied; however, the relationship between their presence and absence has not been examined. The purpose of this study is to analyze the prevalence of the PL, FT, and PM muscles, investigate any relationship of prevalence based on sex or race, and investigate any correlation between the presence or absence of each muscle within individual donors. METHODS Twenty-three willed body donors were comprehensively dissected by medical students, and the presence or absence of the PL, FT, and PM muscles was recorded. RESULTS The PL was present bilaterally in 87% of donors and absent bilaterally in 13%. The FT was present bilaterally in 96% of donors, and present unilaterally in 4% of donors. There was no evidence of total agenesis of the FT within our sample. The PM was present bilaterally in 39% of donors, and absent bilaterally in 61% of donors. No statistically significant relationship was indicated between muscle presence and the sex or race of the donors. No correlation between the presence or absence of each of the muscles was found. CONCLUSION In this sample of willed body donors, there was no relationship between muscular agenesis of the vestigial muscles. This suggests that muscle agenesis is a local genetic developmental event at each muscle, and that there is not a single developmental event that leads to agenesis of multiple vestigial muscles. Further understanding of the agenesis of vestigial structures within populations and subpopulations can aid in physician diagnosis and understanding of the anatomical makeup of individuals.
Collapse
Affiliation(s)
- Blake H Hodgens
- Cell Biology, University of Miami Miller School of Medicine, Miami, USA
| | - Matthew J McSoley
- Cell Biology, University of Miami Miller School of Medicine, Miami, USA
| | - Jacob E Milner
- Cell Biology, University of Miami Miller School of Medicine, Miami, USA
| | - Kunal P Naik
- Cell Biology, University of Miami Miller School of Medicine, Miami, USA
| | - Kaleb R Howard
- Cell Biology, University of Miami Miller School of Medicine, Miami, USA
| | - Ean Schwartz
- Cell Biology, University of Miami Miller School of Medicine, Miami, USA
| | - David P Matichak
- Cell Biology, University of Miami Miller School of Medicine, Miami, USA
| | - Thomas H Champney
- Cell Biology, University of Miami Miller School of Medicine, Miami, USA
| |
Collapse
|